Catalent Supports Lilly’s Clinical Trials Needs, Makes Major Invetsment
Catalent recently announced that it is to install new automated prefilled syringe clinical packaging lines at its Philadelphia Clinical Supply Center of Excellence, in support of the growth of its strategic partner, Eli Lilly.
Catalent already has automated prefilled syringe packaging capabilities in its clinical supply facility in Schorndorf, Germany, providing end-to-end clinical supply solutions from clinical supply management, comparator sourcing and primary packaging to storage and distribution globally.
The packaging line is capable of the fully automated insertion of plunger rods, application of randomized and non-randomized labels and back-stop clips, and off-line labeling with booklet labels. This investment reflects a strong commitment from both Catalent and Eli Lilly to continue shared growth strategies, risks, and to build a long term strategic partnership.
“Our continued investments in clinical packaging, cold chain storage, digital solutions, and our expansion into China are all part of our growth strategy and commitment to our customers to help them reduce clinical trial timelines,” commented Gerry Hepburn, Chief Operating Officer, Vice President and General Manager of Catalent’s Clinical Supply Services business. “Our strategic partnership with Eli Lilly supports their innovation by bringing more products faster to market.”
For more information on Catalent’s Clinical Supply services, please visit: http://www.catalent.com/index.php/offerings/A-Z-Offerings/clinical-overview/clinical-supply-services.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance, and ensuring reliable clinical and commercial product supply. For more information, visit www.catalent.com.
Total Page Views: 1360
